Diagnostic and Equipment Market

The major driving factors for hematology and oncology diagnostics market include increasing incidences of blood related disorders. Approximately 9.8% of the population in U.S. was diagnosed with leukemia by Leukemia & Lymphoma Society (LLS). About 1,658,370 new cases of cancer in 2015 were found due to myeloma and lymphoma. Based on the type of product, global hematology diagnostics market is divided into hematology analysers market and hematology reagents market. Hematology analysers perform complete blood picture, coagulation or erythrocyte sedimentation rates tests. In recent years, the use of hematology diagnostics market has increased due to technological advancements rising demands for improved healthcare facilities. Introduction of digital imaging systems in hematology and oncology laboratories and growing use of microfluidics technology in hematology analysers is another best approach for the growth of  global hematology diagnostics market. Clinical Hematology laboratories are primarily focused on measuring whole blood components such as white blood cells, red blood cells, platelets as well as the level of hemoglobin in the blood.

 

  • Track 1-1 Fresh frozen plasma
  • Track 2-2 Dried factors
  • Track 3-3 Diagnostic Equipments
  • Track 4-4 Technological Advancements
  • Track 5-5 Performance Based Market

Related Conference of Hematology